Pharma Journalist 8801 posts 0 comments

Takeda Pharmaceutical Company Limited announced that it has acquired PvP Biologics, Inc. following the conclusion of a Phase 1 proof-of-mechanism study of investigational medicine…
Read More...

Takeda Pharmaceutical Company Limited announced that it has acquired PvP Biologics, Inc. following the conclusion of a Phase 1 proof-of-mechanism study of investigational medicine…
Read More...

Tonix Pharmaceuticals Holding Corp. announced a strategic collaboration with Southern Research to support the development of a vaccine, TNX-1800 (live modified horsepox virus vaccine…
Read More...

Novavax, Inc. announced progress in its efforts to develop a novel vaccine to protect against coronavirus disease COVID-19. Novavax has produced and is currently assessing multiple…
Read More...

Sandoz is making a public commitment to ensure stable pricing for a basket of essential medicines the company markets, which may help to treat coronavirus patients, amid growing…
Read More...

Gilead Sciences announced the initiation of two Phase 3 clinical studies to evaluate the safety and efficacy of remdesivir in adults diagnosed with COVID-19 (novel coronavirus). These…
Read More...

SMi Reports: Alie Jahangir from Janssen Pharmaceutical to speak at Pre-Filled Syringes East Coast returning to Boston USA, in April. With SMi’s highly sought after Pre-Filled…
Read More...

ProBioGen AG announced that ImmunOs Therapeutics AG has signed a Manufacturing Services Agreement for their novel platform of multitasking biologics. ProBioGen will support ImmunOs in…
Read More...

Perrigo Company plc and its partner, Catalent Pharma Solutions, announced that the U.S. Food and Drug Administration (FDA) has approved Perrigo’s abbreviated new drug application for…
Read More...

BioFIT 2019: A great first edition in Marseille For its first phocean edition, BioFIT confirms its status as the leading European partnering event for early-stage deals and…
Read More...